← All trials
NCT00814372
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2008
- Primary completion
- Feb 1, 2010
- Completion date
- Feb 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 242
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- CymaBay Therapeutics, Inc.Lead sponsor
- American Institute of ResearchOverall official - principal investigator
- Dr. V. Seshiah Diabetes Care & Research InstituteOverall official - principal investigator
- Bharti Research Institute of Diabetes & EndocrinologyOverall official - principal investigator
- BYL Nair HospitalOverall official - principal investigator
- Bangalore Diabetes CentreOverall official - principal investigator
- Deenanath Mangeshkar Hospital & Research CentreOverall official - principal investigator
- Diabetes Thyroid Hormone Research Institute Pvt. Ltd.Overall official - principal investigator
- Mediciti HospitalOverall official - principal investigator
- Amrita Institute of Medical SciencesOverall official - principal investigator
- Association of International Professionals, dba Nevada Alliance Against DiabetesOverall official - principal investigator
- Kamineni Hospitals Pvt, Ltd.Overall official - principal investigator
- Providence Clinical ResearchOverall official - principal investigator
- Fortis Hospitals, IndiaOverall official - principal investigator
- P.D. Hinduja Hospital and Medical Research Centre, MumbaiOverall official - principal investigator
- Medwin Hospital, Hyderabad, AP, IndiaOverall official - principal investigator
- Rajiv Gandhi University of Health SciencesOverall official - principal investigator
- PMG ResearchOverall official - principal investigator
- All India Institute of Medical SciencesOverall official - principal investigator
- Diacon Hospital, BangaloreOverall official - principal investigator
- DGD ResearchOverall official - principal investigator
- Kasturba Medical CollegeOverall official - principal investigator
- M.S. Ramaiah Medical College, Bangalore, IndiaOverall official - principal investigator
- Christian Medical College, Vellore, IndiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.